SICOT2018: Assessing efficacy of ESWT for treatment of bone marrow edema syndrome
SICOT2018: Assessing efficacy of ESWT for treatment of bone marrow edema syndrome
COULD THE ESWT BE A VALID OPTION TO TREAT THE BONE MARROW EDEMA SYNDROME OF THE KNEE?: PRELIMINARY RESULTS IN A PROSPECTIVE RANDOMISED STUDY
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
20 patients with bone marrow edema syndrome of the knee were randomized to treatment with either extracorporeal shockwave therapy or bisphosphonate therapy. Patients were assessed for outcome over the first year of follow-up. Results demonstrated no significant difference in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), visual analog scale pain scores, or resolution of bo...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.